Cargando…

Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”

Detalles Bibliográficos
Autores principales:	Calzetta, Luigino, Rogliani, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309134/ https://www.ncbi.nlm.nih.gov/pubmed/35731338 http://dx.doi.org/10.1007/s12325-022-02213-2

Ejemplares similares

A Response to: Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”
por: Menzies-Gow, Andrew, et al.
Publicado: (2022)

Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab
por: Menzies-Gow, Andrew, et al.
Publicado: (2022)

Clinical Interpretation of Efficacy Outcomes in Pharmacological Studies on Triple Fixed-Dose Combination Therapy for Uncontrolled Asthma: Assessment of IRIDIUM and ARGON Studies
por: Rogliani, Paola, et al.
Publicado: (2022)

Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis
por: Caruso, Cristiano, et al.
Publicado: (2022)

Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis
por: D'Amato, Maria, et al.
Publicado: (2022)

Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy
por: Cazzola, Mario, et al.
Publicado: (2020)

Strength of association between comorbidities and asthma: a meta-analysis
por: Rogliani, Paola, et al.
Publicado: (2023)

Mortality in ETHOS: A Question of “Power”
por: Rogliani, Paola, et al.
Publicado: (2021)

Sex differences in adult asthma and COPD therapy: a systematic review
por: Rogliani, Paola, et al.
Publicado: (2022)

Oral Corticosteroids Dependence and Biologic Drugs in Severe Asthma: Myths or Facts? A Systematic Review of Real-World Evidence
por: Calzetta, Luigino, et al.
Publicado: (2021)

Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis
por: Rogliani, Paola, et al.
Publicado: (2019)

Dysfunction of small airways and prevalence, airway responsiveness and inflammation in asthma: much more than small particle size of pet animal allergens
por: Liccardi, Gennaro, et al.
Publicado: (2016)

Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile
por: Rogliani, Paola, et al.
Publicado: (2022)

Severe Asthma and Biological Therapy: When, Which, and for Whom
por: Rogliani, Paola, et al.
Publicado: (2019)

Experimental Glucocorticoid Receptor Agonists for the Treatment of Asthma: A Systematic Review
por: Rogliani, Paola, et al.
Publicado: (2020)

Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized Medicine
por: Calzetta, Luigino, et al.
Publicado: (2017)

Is the risk of developing atopic sensitization and bronchial asthma in animal laboratory workers preventable in well-defined susceptible individuals?
por: Liccardi, Gennaro, et al.
Publicado: (2017)

The Impact of Monoclonal Antibodies on Airway Smooth Muscle Contractility in Asthma: A Systematic Review
por: Calzetta, Luigino, et al.
Publicado: (2021)

Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma
por: Calzetta, Luigino, et al.
Publicado: (2022)

Letter to the Editor: Regarding COVID-19 in Children with Asthma
por: Özdemir, Öner
Publicado: (2021)

Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics
por: Principe, Stefania, et al.
Publicado: (2019)

Impact of Sex on Proper Use of Inhaler Devices in Asthma and COPD: A Systematic Review and Meta-Analysis
por: Calzetta, Luigino, et al.
Publicado: (2022)

SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines
por: Rogliani, Paola, et al.
Publicado: (2021)

Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative review
por: Matera, Maria Gabriella, et al.
Publicado: (2020)

Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses
por: Cazzola, Mario, et al.
Publicado: (2019)

Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to Patients
por: Calzetta, Luigino, et al.
Publicado: (2019)

Editorial overview: Respiratory: Pulmonary pharmacology–The emergence of new treatments in pulmonary medicine is finally providing real therapeutic perspectives
por: Cazzola, Mario, et al.
Publicado: (2021)

Long-Term Efficacy and Clinical Remission After Benralizumab Treatment in Patients with Severe Eosinophilic Asthma: A Retrospective Study
por: Numata, Takanori, et al.
Publicado: (2022)

The clinical use of regenerative therapy in COPD
por: Lipsi, Roberto, et al.
Publicado: (2014)

Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease
por: Ora, Josuel, et al.
Publicado: (2020)

Dexamethasone in Patients Hospitalized with COVID-19: Whether, When and to Whom
por: Calzetta, Luigino, et al.
Publicado: (2021)

Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score
por: Rogliani, Paola, et al.
Publicado: (2022)

The Impact of Corticosteroids on Human Airway Smooth Muscle Contractility and Airway Hyperresponsiveness: A Systematic Review
por: Calzetta, Luigino, et al.
Publicado: (2022)

The clinical profile of benralizumab in the management of severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab
por: Just, Jocelyne, et al.
Publicado: (2020)

Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma
por: Noorduyn, Stephen G., et al.
Publicado: (2021)

Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma
por: Gómez-Bastero Fernández, Ana, et al.
Publicado: (2022)

Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
por: Singh, Dave, et al.
Publicado: (2023)

Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation
por: Cazzola, Mario, et al.
Publicado: (2017)

Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways
por: Calzetta, Luigino, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4gknlpesksumu53aatg47fjtai